메뉴 건너뛰기




Volumn 28, Issue 6, 2003, Pages 489-491

Differentiation of Synchronous Tumors Using FDG Positron Emission Tomography

Author keywords

F 18 Fluorodeoxyglucose; Non Small Cell Lung Cancer; Pancreatic Endocrine Tumor; Positron Emission Tomography; Squamous Cell Carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

EID: 0041733908     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200306000-00009     Document Type: Article
Times cited : (5)

References (7)
  • 1
    • 0031900605 scopus 로고    scopus 로고
    • 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behaviour?
    • 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behaviour? World J Surg 22:588, 1998.
    • (1998) World J Surg , vol.22 , pp. 588
    • Pasquali, C.1    Rubello, D.2    Sperti, C.3
  • 2
    • 0031910371 scopus 로고    scopus 로고
    • Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours
    • Adams S, Baum R, Rink T, et al: Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79, 1998.
    • (1998) Eur J Nucl Med , vol.25 , pp. 79
    • Adams, S.1    Baum, R.2    Rink, T.3
  • 3
    • 0034074097 scopus 로고    scopus 로고
    • Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies
    • Eriksson B, Bergstrom M, Orlefors H, et al: Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies. Q J Nucl Med 44:68, 2000.
    • (2000) Q J Nucl Med , vol.44 , pp. 68
    • Eriksson, B.1    Bergstrom, M.2    Orlefors, H.3
  • 4
    • 0035748669 scopus 로고    scopus 로고
    • Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?
    • Bombardieri E, Maccauro M, Castellani MR, et al: Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure? Minerva Endocrinol 26: 197, 2001.
    • (2001) Minerva Endocrinol , vol.26 , pp. 197
    • Bombardieri, E.1    Maccauro, M.2    Castellani, M.R.3
  • 5
    • 0027276202 scopus 로고
    • Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors
    • Eriksson B, Bergstrom M, Lilja A, et al: Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncol 32:189, 1993.
    • (1993) Acta Oncol , vol.32 , pp. 189
    • Eriksson, B.1    Bergstrom, M.2    Lilja, A.3
  • 6
    • 0028962933 scopus 로고
    • Pancreatic neuroendocrine tumors: Diagnosis with PET
    • Ahlstrom H, Eriksson B, Bergstrom M, et al: Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 195:320, 1995.
    • (1995) Radiology , vol.195 , pp. 320
    • Ahlstrom, H.1    Eriksson, B.2    Bergstrom, M.3
  • 7
    • 0030475781 scopus 로고    scopus 로고
    • Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
    • Rigo P, Paulus P, Kaschten BJ, et al: Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641, 1996.
    • (1996) Eur J Nucl Med , vol.23 , pp. 1641
    • Rigo, P.1    Paulus, P.2    Kaschten, B.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.